Ideas & society2021 · shared on Hacker News
Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
Explore Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind, its original source and Hacker News discussions. Discover community perspectives and save it to your reading list.
GO BEYOND THE ABSTRACT
The conversation around the idea.
Original Hacker News threads. Different perspectives, questions, and things worth thinking about.
Showing up to 100 related threads. A paper may appear in a comment rather than the original submission.
Links found in the discussion
Up to 50 recent source links, in HN item order.
Ylolspace ·
Ivermectin shows clinical benefits in mild to moderate COVID19: RCT double-blind
47 points52 comments